通过嗜碱性粒细胞活化试验监测奥马珠单抗治疗慢性荨麻疹的疗效。 - Suppr

Suppr

超能文献

Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.

作者信息

Rodríguez-Trabado A, Fernández Pereira L M, Romero-Chala S, García-Trujillo J A, Cámara Hijón C

出版信息

Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.

DOI:10.1016/j.aller.2011.09.009

PMID:22178123

Abstract

摘要

相似文献

Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.

Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.

A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.

Ann Allergy Asthma Immunol. 2014 Apr;112(4):276-9. doi: 10.1016/j.anai.2014.01.019. Epub 2014 Feb 28.

Omalizumab is effective in nonautoimmune urticaria.

J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.

J Dermatol Sci. 2014 Jan;73(1):57-62. doi: 10.1016/j.jdermsci.2013.08.011. Epub 2013 Sep 3.

An algorithm for treating chronic urticaria with omalizumab: dose interval should be individualized.

J Allergy Clin Immunol. 2014 Mar;133(3):914-5.e2. doi: 10.1016/j.jaci.2013.10.015. Epub 2013 Dec 18.

Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):529-30. doi: 10.1016/j.jaip.2015.11.025. Epub 2015 Dec 24.

Omalizumab for chronic urticaria.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):118-9. doi: 10.1016/j.jaip.2013.11.004.

Omalizumab in chronic urticaria.

Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a.

Treatment of chronic autoimmune urticaria with omalizumab.

J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.

Extraordinary response to omalizumab in a child with severe chronic urticaria.

Eur Ann Allergy Clin Immunol. 2014 Jan;46(1):41-2.

引用本文的文献

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.

Front Immunol. 2024 Aug 20;15:1413233. doi: 10.3389/fimmu.2024.1413233. eCollection 2024.

Pros and Cons of Clinical Basophil Testing (BAT).

Curr Allergy Asthma Rep. 2016 Jul;16(8):56. doi: 10.1007/s11882-016-0633-6.

Guideline of Chronic Urticaria Beyond.

Allergy Asthma Immunol Res. 2016 Sep;8(5):396-403. doi: 10.4168/aair.2016.8.5.396.

Immunotherapy in allergy and cellular tests: state of art.

Hum Vaccin Immunother. 2014;10(6):1595-610. doi: 10.4161/hv.28592. Epub 2014 May 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Monitoring omalizumab treatment efficacy in chronic urticaria by the basophil activation test.

Allergol Immunopathol (Madr). 2012 Nov-Dec;40(6):390-2. doi: 10.1016/j.aller.2011.09.009. Epub 2011 Dec 15.

A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.

Ann Allergy Asthma Immunol. 2014 Apr;112(4):276-9. doi: 10.1016/j.anai.2014.01.019. Epub 2014 Feb 28.

Omalizumab is effective in nonautoimmune urticaria.

J Allergy Clin Immunol. 2011 May;127(5):1300-2. doi: 10.1016/j.jaci.2010.12.1085. Epub 2011 Feb 11.

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.

J Dermatol Sci. 2014 Jan;73(1):57-62. doi: 10.1016/j.jdermsci.2013.08.011. Epub 2013 Sep 3.

An algorithm for treating chronic urticaria with omalizumab: dose interval should be individualized.

J Allergy Clin Immunol. 2014 Mar;133(3):914-5.e2. doi: 10.1016/j.jaci.2013.10.015. Epub 2013 Dec 18.

Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria.

J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):529-30. doi: 10.1016/j.jaip.2015.11.025. Epub 2015 Dec 24.

Omalizumab for chronic urticaria.

J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):118-9. doi: 10.1016/j.jaip.2013.11.004.

Omalizumab in chronic urticaria.

Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a.

Treatment of chronic autoimmune urticaria with omalizumab.

J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.

Extraordinary response to omalizumab in a child with severe chronic urticaria.

Eur Ann Allergy Clin Immunol. 2014 Jan;46(1):41-2.

引用本文的文献

Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.

Front Immunol. 2024 Aug 20;15:1413233. doi: 10.3389/fimmu.2024.1413233. eCollection 2024.

Pros and Cons of Clinical Basophil Testing (BAT).

Curr Allergy Asthma Rep. 2016 Jul;16(8):56. doi: 10.1007/s11882-016-0633-6.

Guideline of Chronic Urticaria Beyond.

Allergy Asthma Immunol Res. 2016 Sep;8(5):396-403. doi: 10.4168/aair.2016.8.5.396.

Immunotherapy in allergy and cellular tests: state of art.

Hum Vaccin Immunother. 2014;10(6):1595-610. doi: 10.4161/hv.28592. Epub 2014 May 2.